Andy P. Rasdal , MBA

CEO

Obalon Therapeutics, Inc.
Carlsbad, CA

Andy P. Rasdal is the CEO of Obalon Therapeutics, Inc. an engineering-driven medical technology company. Prior to joining Obalon, Mr. Rasdal served as CEO of DexCom, Inc. (NASDAQ:DXCM) and as Senior Vice President and President of Vascular for Medtronic, Inc (NYSE:MDT) Prior to that, he was Vice President of Marketing for Arterial Vascular Engineering (NASDAQ:AVEI). He has also held various positions at EP Technologies (NASDAQ:EPTI), SciMed Life Systems (NASDAQ:SMLS) and Advanced Cardiovascular Systems. He holds a B.S. from San Jose State University and an M.B.A. from J.L. Kellogg School of Management, Northwestern University.